Mo, Ni
Tai, Chuyang
Yang, Yang
Ling, Cong
Zhang, Baoyu
Wei, Lei
Yao, Cian
Wang, Hui
Chen, Chuan
Funding for this research was provided by:
Guangzhou Key Research and Development Program under Grant (2023B03J0191)
Research Project of Yuedong Hospital, the Third Affiliated Hospital of Sun Yat-sen University under Grant (YDC2022001)
Basic Research Project of Sun Yat-sen University (b202408011053050001)
Article History
Received: 9 October 2024
Accepted: 22 January 2025
First Online: 6 February 2025
Declarations
:
: The study was conducted following the Declaration of Helsinki; the Ethics Committee of the third affiliated hospital of Sun Yat-sen university, China, approved the study (II2024-091). Informed consent was obtained from all subjects involved in the study. The animal experiment was performed in compliance with the ARRIVE guidelines and approved by the Animal Ethics Committee of Guangzhou Huateng Biopharmaceutical Technology Co., Ltd. (IACUC No. C202304-5).
: All authors give consent for the publication of the manuscript in Journal of Translational Medicine.
: The authors declare that they have no competing interests.